RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Australia, New Zealand Launch Next Phase of Regulatory Harmonization Effort

Australia, New Zealand Launch Next Phase of Regulatory Harmonization Effort

Posted 14 November 2013 | By Louise Zornoza

Australia's Therapeutic Goods Administration (TGA) and New Zealand's Medicines and Medical Devices Safety Authority (Medsafe) announced on 13 November 2013 the next stage of their joint efforts toward regulatory harmonization and the launch of a joint regulatory agency, the Australia New Zealand Therapeutic Products Agency (ANZTPA)..

This new phase of joint work will cover the next two and a half years and targets 14 activities across the following six regulatory areas: medicines (prescription and non-prescription), medicines ingredients, safety, medical devices, and biological and blood products.

The Medsafe/TGA ANZTPA Implementation Steering Committee will oversee the multiple harmonization activities to link with the ongoing Australian Blueprint reforms program and the needed timing for ANZTPA Rules and Orders development.

ANZTPA Statement

Read all Breaking News from RegLink

Regulatory Focus newsletters

All the biggest regulatory news and happenings.


Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.